Screening of Diabetic Retinopathy Using Artificial Intelligence and Tele-Ophthalmology.
作者信息
Kuklinski Eric J, Henry Roger K, Shah Megh, Zarbin Marco A, Szirth Bernard, Bhagat Neelakshi
机构信息
Rutgers New Jersey Medical School, Newark, NJ, USA.
Department of Ophthalmology, Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.
出版信息
J Diabetes Sci Technol. 2023 Nov;17(6):1724-1725. doi: 10.1177/19322968231194041. Epub 2023 Aug 29.
Abstract
摘要
相似文献
1
Screening of Diabetic Retinopathy Using Artificial Intelligence and Tele-Ophthalmology.
J Diabetes Sci Technol. 2023 Nov;17(6):1724-1725. doi: 10.1177/19322968231194041. Epub 2023 Aug 29.
2
Sociodemographics Associated With Risk of Diabetic Retinopathy Detected by Tele-Ophthalmology: 5-Year Results of the Toronto Tele-Retinal Screening Program.
Can J Diabetes. 2022 Feb;46(1):26-31. doi: 10.1016/j.jcjd.2021.05.001. Epub 2021 May 8.
3
Artificial intelligence for diabetic retinopathy screening, prediction and management.
Curr Opin Ophthalmol. 2020 Sep;31(5):357-365. doi: 10.1097/ICU.0000000000000693.
4
The role of tele-ophthalmology in diabetic retinopathy screening.
J Optom. 2020 Oct-Dec;13(4):262-268. doi: 10.1016/j.optom.2019.12.004. Epub 2020 Jan 14.
5
Progress in examining cost-effectiveness of AI in diabetic retinopathy screening.
Lancet Digit Health. 2020 May;2(5):e212-e213. doi: 10.1016/S2589-7500(20)30077-7. Epub 2020 Apr 23.
6
The Role of Retinal Imaging and Portable Screening Devices in Tele-ophthalmology Applications for Diabetic Retinopathy Management.
Curr Diab Rep. 2016 Dec;16(12):132. doi: 10.1007/s11892-016-0827-2.
7
The impact of artificial intelligence in screening for diabetic retinopathy in India.
Eye (Lond). 2020 Mar;34(3):420-421. doi: 10.1038/s41433-019-0626-5. Epub 2019 Dec 11.
8
Great expectations and challenges of artificial intelligence in the screening of diabetic retinopathy.
Eye (Lond). 2020 Mar;34(3):418-419. doi: 10.1038/s41433-019-0629-2. Epub 2019 Dec 11.
9
The Challenge of Diabetic Retinopathy Standardization in an Ophthalmological Dataset.
J Diabetes Sci Technol. 2021 Nov;15(6):1410-1411. doi: 10.1177/19322968211029943. Epub 2021 Jul 14.
10
Five-year experience of tele-ophthalmology for diabetic retinopathy screening in a rural population.
Arch Soc Esp Oftalmol. 2016 Sep;91(9):426-30. doi: 10.1016/j.oftal.2016.01.023. Epub 2016 Feb 18.
引用本文的文献
1
Intravitreal OZURDEX vs. Intravitreal Bevacizumab for Diabetic Macular Edema: A Comprehensive Review.
Cureus. 2024 Mar 23;16(3):e56796. doi: 10.7759/cureus.56796. eCollection 2024 Mar.
2
Innovations in Diabetic Macular Edema Management: A Comprehensive Review of Automated Quantification and Anti-vascular Endothelial Growth Factor Intervention.
Cureus. 2024 Feb 23;16(2):e54752. doi: 10.7759/cureus.54752. eCollection 2024 Feb.
本文引用的文献
1
Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.
JAMA Ophthalmol. 2022 Apr 1;140(4):401-409. doi: 10.1001/jamaophthalmol.2022.0223.
2
Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
BMC Health Serv Res. 2022 Feb 25;22(1):260. doi: 10.1186/s12913-022-07655-6.
3
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers.
Eur J Ophthalmol. 2022 Jan;32(1):695-703. doi: 10.1177/11206721211002442. Epub 2021 Mar 16.
4
Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care.
JAMA Ophthalmol. 2021 May 1;139(5):508-515. doi: 10.1001/jamaophthalmol.2021.0114.
5
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
6
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010.
Diabetes Care. 2016 Sep;39(9):1643-9. doi: 10.2337/dc15-2171.
Zotero 插件